Apr 13, 2020

2 Israeli COVID-19 patients said to improve in experimental drug trial

Posted by in category: biotech/medical

“Our hope is that the unique mechanism of action of Opaganib, with both anti-viral and anti-inflammatory activity, will help COVID-19 patients by reducing lung inflammation, and thus preventing the disease from progressing to a stage which requires mechanical ventilation,” said Mark L. Levitt, RedHill’s medical director.

Comments are closed.